Recordings
2025
January 16th, 2025: Miguel Arce and Emily Briceño-Abreu, “Cross-national harmonization of the Harmonized Cognitive Assessment Protocol (HCAP)”
2024
November 21st, 2024: Yingyan Wu, “How to assess cognitive decline when test administration changes across study waves? Harmonizing cognitive scores across waves in CHARLS”
October 17th, 2024: Mary Thoma, “Are we there yet? Estimating the waves of follow-up required for stable estimates in cognitive aging research”
October 3rd, 2024: Dr. Vijaya Kolachalama, “Multimodal machine learning for differential dementia diagnosis”
September 19th, 2024: Dr. Roopal Desai & Dr. Verena Zuber, “Examining the Lancet Commission on risk factors for dementia using Mendelian Randomization”
September 5th, 2024: Dr. Phil Cantu, “Differential Item Functioning of informant measures of cognitive functioning in the U.S. and Mexico”
May 16th, 2024: Dr. Gabriel L. Schwartz, “Housing insecurity, foreclosure, and cognitive aging”
April 18th, 2024: Dr. Byron Jaeger, “Oblique and causal random forests”
March 21st, 2024: Dr. Erin Ferguson, “Robustness of effect estimates to varying model specifications”
March 7th, 2024: Dr. Joan Monin, “Systolic Blood Pressure During Conversations between Older Adults Living with Cognitive Impairment and their Children: Associations with Attachment Security”
February 29th, 2024: Dr. Eleanor Hayes-Larson, “Implications of timescale choice for estimated effects of exposures on rate of cognitive change among older adults: Results from the 2022 MELODEM Data Workshop”
February 1st, 2024: DEBATE, Dr. David Wallon, “Are anti-amyloid immunotherapies’disease modifying’ or symptomatic treatments for Alzheimer’s disease?” & Dr. Vincent Planche “Are anti-amyloid immunotherapies disease-modifying or symptomatic treatment for early AD?”
See Slides: David Wallon Slides & Vincent Planche Slides
January 18th, 2024: Dr. Maria Glymour, “Evidence Triangulation and Dementia Research”
2023
December 14th, 2023: Dr. Rachel Whitmer, “Launching Cohort Studies within Integrated Healthcare Delivery Systems Vs Communities: Opportunities for Life-course Epidemiology”
November 30th, 2023: Dr. Zachary Kunicki, “Understanding Normative Cognitive Aging”
November 16th, 2023: Dr. Carole Dufouil, “The MEMENTO Cohort: Update on Data Availability Access Procedures”
October 19th, 2023: Dr. Aayush Khadka, “Quantile regressions for quantifying heterogeneities in the education-cognition relationship”
October 5th, 2023: Dr. Paloma Rojas-Saunero, “Effect of incident stroke on the risk of dementia over a period of 10 years of follow-up in a cohort of Asian American and white older adults in California”
September 21st, 2023: Dr. Suzanne Judd, “REGARDS and RURAL – Cohorts for Potential Dementia Questions” & “Cognitive Impairment in REGARDS”
See Slides: Slide deck 1 & Slide deck 2
April 20th, 2023: Dr. Jennifer J. Manly, “Methods for Estimating National Prevalence of Dementia and MCI from the Harmonized Cognitive Assessment Protocol Project”
April 6th, 2023: Dr. Maude Wagner, “Using Longitudinal Continuous Measures to Capture Key Complementary Dimensions of Cognitive Resilience to AD Neuropathology”
March 16th, 2023: Dr. Roch A. Nianogo, “Risk Factors Associated with Alzheimer Disease and Related Dementias by Sex and Race and Ethnicity in the US”
March 2nd, 2023: Dr. Lon S. Schneider, “Lecanemab: effectiveness, approval, and why it takes a village”
February 16th, 2023: Dr. Terry M Therneau, “Competing risks and the Fine-Gray model”
February 2nd, 2023: Dr. Erin E. Bennett, “Methodological considerations in target trial emulation using cohort studies: estimating the effect of antihypertensive medication initiation on incident dementia in ARIC, CHS, and HRS”
January 19th, 2023: Dr. Marina Sirota, “Leveraging Molecular and Clinical Data to Better Understand Alzheimer’s Disease”
2022
December 15th, 2022: Dr. Sepideh Modrek, & Dr. David Rehkopf, “Long-term effects of Local Area New Deal Work-Relief in Childhood on Educational and Cognitive Outcomes over the Life Course”
December 1st, 2022: Dr. Tara E. Jenson, “Environmental Cadmium Exposures, Cognitive Performance in Older Adults, and Subsequent Alzheimer’s Disease Mortality”
November 3rd, 2022: Dr. Tianhao Wang, “The ‘cognitive clock’: A novel indicator of brain health”
October 20th, 2022: Dr. Emma Nichols, “The use of algorithms for the identification of incident dementia: challenges and potential biases”
October 6th, 2022: Dr. John (Rob) Warren, “High School & Beyond: Turning an Education Cohort Study into an ADRD Study”
September 15th, 2022: Dr. Marcia P Jimenez & Dr. L. Paloma Rojas-Saunero, “Racial and ethnic differences in the risk of dementia under hypothetical blood-pressure-lowering interventions: The Multi-Ethnic Study of Atherosclerosis”
2021
November 18th, 2021: Dr. Madhav Thambisetty, “From Mechanisms to Medicines: realizing the DREAM of an Alzheimer’s cure”
October 28th, 2021: Dr. Venexia Walker, “Predicting drug repurposing opportunities for Alzheimer’s disease prevention using genome-wide association study data”
October 8th, 2021: Dr. Maria Glymour, “Introduction to using Directed Acyclic Graphs in dementia research”
July 15th, 2021: Dr. Thomas Nedelec, “Data-driven identification of health conditions associated with incident Alzheimer’s disease dementia risk: a 15 years follow-up cohort from electronic health records in France and the United Kingdom”
April 29th, 2021: “Re-orienting to MELODEM”
April 1st, 2021: Dr. Zach Baucom, “Using State Space Models for Longitudinal Neuropsychological Outcomes”
March 18th, 2021: Dr. Lon Schneider, “Methodological features and FDA’s regulatory guidance on aducanumab and Alzheimer drug development”
March 4th, 2021: Dr. Terry Therneau, “Multi-state survival models and dementia”
February 18th, 2021: Dr. Andrew Stokes, “Estimations of the Association of Dementia with US Mortality Levels Using Linked Survey and Mortality Records”
February 11th, 2021: Dr. Julie Zissimopoulos, “Drug therapies for chronic conditions and risk of ADRD: analyses using claims data”
February 4th, 2021: Dr. Justina Avila-Rieger, “Using Multilevel Analysis of Individual Heterogeneity & Discriminatory Accuracy (MAIHDA) to Examine Intersectional Inequalities in Cognitive Aging”
2020
December 10th, 2020: Dr. Maria Corrada & Dr. Sevil Yasar, “Statin Use, Hx of High Cholesterol & Risk of Dementia in the Oldest-old: illustration of challenges when analyzing pharmacoepidemiological data”
December 3rd, 2020: Dr. Eric Tchetgen Tchetgen, “MR GENIUS: A Principled Approach to Robust Mendelian Randomization Interference”
July 9th, 2020: Dr. Bryan James, “Implications of covid for dementia researchers”